Gastric cancer: Animal studies on the risk of hypoacidity and hypergastrinemia

World Journal of Gastroenterology

Volumn 14, Issue 11, 2008, Pages 1646-1651

  Fossmark, Reidar ^a,b   Qvigstad, Gunnar ^a,b   Waldum, Helge L ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

Acid secretion; Animal model; Gastric cancer; Gastrin; Proton pump inhibitors

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; CHROMOGRANIN A; CIPROFIBRATE; GASTRIN; GASTRIN RECEPTOR; GENE PRODUCT; HISTAMINE; LOXTIDINE; MESSENGER RNA; OMEPRAZOLE; PROTEIN REG; RANITIDINE; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

CANCER GROWTH; CANCER RISK; CARCINOID; CELL FUNCTION; CELL PROLIFERATION; COTTON RAT; DISEASE ASSOCIATION; DISEASE MODEL; ENTEROCHROMAFFIN LIKE CELL; GERBIL; HUMAN; HYPERGASTRINEMIA; NONHUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SPECIES DIFFERENCE; STOMACH ACID SECRETION; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH GLAND; STOMACH MUCOSA;

EID: 41849104665     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.1646     Document Type: Review

References (80)

1. Kokkola A, Sjoblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Jarvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol 1998; 33: 88-92
2. Sjoblom SM, Sipponen P, Miettinen M, Karonen SL, Jrvinen HJ. Gastroscopic screening for gastric carcinoids and carcinoma in pernicious anemia. Endoscopy 1988; 20: 52-56
3. Hsing AW, Hansson LE, McLaughlin JK, Nyren O, Blot WJ, Ekbom A, Fraumeni JF Jr. Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer 1993; 71: 745-750
4. Sjoblom SM, Sipponen P, Karonen SL, Jarvinen HJ. Argyrophilic cell hyperplasia and carcinoid tumors in oxyntic mucosa of the stomach. Dependence on duration of pernicious aniaemia. Eur J Gastroenterol Hepatol 1991; 3: 153-157
5. Rindi G, Fiocca R, Morocutti A, Jacobs A, Miller N, Thjodleifsson B. Effects of 5 years of treatment with rabeprazole or omeprazole on the gastric mucosa. Eur J Gastroenterol Hepatol 2005; 17: 559-566
6. Schott M, Sagert C, Willenberg HS, Schinner S, Ramp U, Varro A, Raffel A, Eisenberger C, Zacharowski K, Perren A, Scherbaum WA. Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome. J Clin Endocrinol Metab 2007; 92: 3378-3382
7. Lehy T, Cadiot G, Mignon M, Ruszniewski P, Bonfils S. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 1992; 33: 1275-1279
8. Cadiot G, Vissuzaine C, Potet F, Mignon M. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome. Dig Dis Sci 1995; 40: 1275-1278
9. Feurle GE. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome. Gut 1994; 35: 275-277
10. Waldum HL, Fossmark R, Bakke I, Martinsen TC, Qvigstad G. Hypergastrinemia in animals and man: causes and consequences. Scand J Gastroenterol 2004; 39: 505-509
11. Waldum HL, Gustafsson B, Fossmark R, Qvigstad G. Antiulcer drugs and gastric cancer. Dig Dis Sci 2005; 50 Suppl 1: S39-S44
12. Edkins JS. On the chemical mechanism of gastric acid secretion. Proc R Soc Med 1905; 76: 376
13. Innis RB, Snyder SH. Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci USA 1980; 77: 6917-6921
14. Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, Kolakowski LF Jr, Beinborn M. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc Natl Acad Sci USA 1992; 89: 3605-3609
15. Waldum HL, Sandvik AK, Brenna E, Petersen H. Gastrin-histamine sequence in the regulation of gastric acid secretion. Gut 1991; 32: 698-701
16. Shankley NP, Welsh NJ, Black JW. Histamine dependence of pentagastrin-stimulated gastric acid secretion in rats. Yale J Biol Med 1992; 65: 613-619
17. Kulaksiz H, Arnold R, Goke B, Maronde E, Meyer M, Fahrenholz F, Forssmann WG, Eissele R. Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach. Cell Tissue Res 2000; 299: 289-298
18. Schmitz F, Goke MN, Otte JM, Schrader H, Reimarm B, Kruse ML, Siegel EG, Peters J, Herzig KH, Folsch UR, Schmidt WE. Cellular expression of CCK-A and CCK-B/ gastrin receptors in human gastric mucosa. Regul Pept 2001; 102: 101-110
19. Cabero JL, Li ZQ, Mardh S. Gastrin potentiates histamine-stimulated aminopyrine accumulation in isolated rat parietal cells. Am J Physiol 1991; 261: G621-G627
20. Bakke I, Qvigstad G, Sandvik AK, Waldum HL. The CCK-2 receptor is located on the ECL cell, but not on the parietal cell. Scand J Gastroenterol 2001; 36: 1128-1133
21. Tanaka S, Hamada K, Yamada N, Sugita Y, Tonai S, Hunyady B, Palkovits M, Falus A, Watanabe T, Okabe S, Ohtsu H, Ichikawa A, Nagy A. Gastric acid secretion in L-histidine decarboxylase-deficient mice. Gastroenterology 2002; 122: 145-155
22. Kobayashi T, Tonai S, Ishihara Y, Koga R, Okabe S, Watanabe T. Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. J Clin Invest 2000; 105: 1741-1749
23. Crean GP, Marshall MW, Rumsey RD. Parietal cell hyperplasia induced by the administration of pentagastrin (ICI 50,123) to rats. Gastroenterology 1969; 57: 147-155
24. Poynter D, Pick CR, Harcourt RA, Selway SA, Ainge G, Harman IW, Spurling NW, Fluck PA, Cook JL. Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat. Gut 1985; 26: 1284-1295
25. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986; 35 Suppl 1: 42-55
26. Havu N, Mattsson H, Ekman L, Carlsson E. Enterochromaffinlike cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine. Digestion 1990; 45: 189-195
27. Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, Wallmark B, Watanabe T, Hakanson R. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats. Gastroenterology 1986; 90: 391-399
28. Sundler F, Hakanson R, Carlsson E, Larsson H, Mattsson H. Hypergastrinemia after blockade of acid secretion in the rat: trophic effects. Digestion 1986; 35 Suppl 1: 56-69
29. Hakanson R, Blom H, Carlsson E, Larsson H, Ryberg B, Sundler F. Hypergastrinaemia produces trophic effects in stomach but not in pancreas and intestines. Regul Pept 1986; 13: 225-233
30. Ryberg B, Tielemans Y, Axelson J, Carlsson E, Hakanson R, Mattson H, Sundler F, Willems G. Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology 1990; 99: 935-942
31. Tielemans Y, Axelson J, Sundler F, Willems G, Hakanson R. Serum gastrin concentration affects the self replication rate of the enterochromaffin like cells in the rat stomach. Gut 1990; 31: 274-278
32. Tielemans Y, Hakanson R, Sundler F, Willems G. Proliferation of enterochromaffinlike cells in omeprazole-treated hypergastrinemic rats. Gastroenterology 1989; 96: 723-729
33. Mattsson H, Havu N, Brautigam J, Carlsson K, Lundell L, Carlsson E. Partial gastric corpectomy results in hypergastrinemia and development of gastric enterochromaffinlike-cell carcinoids in the rat. Gastroenterology 1991; 100: 311-319
34. Spencer AJ, Barbolt TA, Henry DC, Eason CT, Sauerschell RJ, Bonner FW. Gastric morphological changes including carcinoid tumors in animals treated with a potent hypolipidemic agent, ciprofibrate. Toxicol Pathol 1989; 17: 7-15
35. Martinsen TC, Nesjan N, Ronning K, Sandvik AK, Waldum HL. The peroxisome-proliferator ciprofibrate induces hypergastrinemia without raising gastric pH. Carcinogenesis 1996; 17: 2153-2155
36. Waldum HL, Kvetnoi IM, Sylte R, Schulze B, Martinsen TC, Sandvik AK. The effect of the peroxisome proliferator ciprofibrate on the gastric mucosa and particularly the gastrin cell. J Mol Endocrinol 1998; 20: 111-117
37. Poynter D, Selway SA, Papworth SA, Riches SR. Changes in the gastric rnucosa of the mouse associated with long lasting unsurmountable histamine H2 blockade. Gut 1986; 27: 1338-1346
38. Waldum HL, Brenna E, Martinsen TC. Safety of proton pump inhibitors. Aliment Pharmacol Ther 2000; 14: 1537-1538
39. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Raychowdhury R, Coffey RJ, Ito S, Varro A, Dockray GJ, Fox JG. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118: 36-47
40. Takaishi S, Cui G, Frederick DM, Carlson JE, Houghton J, Varro A, Dockray GJ, Ge Z, Whary MT, Rogers AB, Fox JG, Wang TC. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology 2005; 128: 1965-1983
41. Kidd M, Miu K, Tang LH, Perez-Perez GI, Blaser MJ, Sandor A, Modlin IM. Helicobacter pylori lipopolysaccharide stimulates histamine release and DNA synthesis in rat enterochromaffin-like cells. Gastroenterology 1997; 113: 1110-1117
42. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A, Wang TC. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 2003; 63: 942-950
43. Franic TV, Judd LM, Robinson D, Barrett SP, Scarff KL, Gleeson PA, Samuelson LC, Van Driel IR. Regulation of gastric epithelial cell development revealed in H(+)/K(+)-ATPase beta-subunit- and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol 2001; 281: G1502-G1511
44. Scarff KL, Judd LM, Toh BH, Gleeson PA, Van Driel IR. Gastric H(+),K(+)-adenosine triphosphatase beta subunit is required for normal function, development, and membrane structure of mouse parietal cells. Gastroenterology 1999; 117: 605-618
45. Friis-Hansen L, Sundler F, Li Y, Gillespie PJ, Saunders TL, Greenson JK, Owyang C, Rehfeld JF, Samuelson LC. Impaired gastric acid secretion in gastrin-deficient mice. Am J Physiol 1998; 274: G561-G568
46. Friis-Hansen L, Rieneck K, Nilsson HO, Wadstrom T, Rehfeld JF. Gastric inflammation, metaplasia, and tumor development in gastrin-deficient mice. Gastroenterology 2006; 131: 246-258
47. Friis-Hansen L. Achlorhydria is associated with gastric microbial overgrowth and development of cancer: lessons learned from the gastrin knockout mouse. Scand J Clin Lab Invest 2006; 66: 607-621
48. Friis-Hansen L. Lessons from the gastrin knockout mice. Regul Pept 2007; 139: 5-22
49. Willems G, Vansteenkiste Y, Limbosch JM. Stimulating effect of gastrin on cell proliferation kinetics in canine fundic mucosa. Gastroenterology 1972; 62: 583-589
50. Waldum HL, Brenna E, Sandvik AK, Petersen H. Trophic effect of histamine on the stomach. Scand J Gastroenterol Suppl 1991; 180: 137-142
51. Watson SA, Wilkinson LJ, Robertson JF, Hardcastle JD. Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut 1993; 34: 1091-1096
52. Waldum HL, Lehy T, Brenna E, Sandvik AK, Petersen H, Sognen BS, Bonfils S, Lewin MJ. Effect of the histamine-1 antagonist astemizole alone or with omeprazole on rat gastric mucosa. Scand J Gastroenterol 1991; 26: 23-35
53. Brenna E, Tielemans Y, Kleveland PM, Sandvik AK, Willems G, Waldum HL. Effect of the histamine-2 agonist impromidine on stem cell proliferation of rat oxyntic mucosa. Scand J Gastroenterol 1995; 30: 311-314
54. Terazono K, Yamamoto H, Takasawa S, Shiga K, Yonemura Y, Tochino Y, Okamoto H. A novel gene activated in regenerating islets. J Biol Chem 1988; 263: 2111-2114
55. Asahara M, Mushiake S, Shimada S, Fukui H, Kinoshita Y, Kawanami C, Watanabe T, Tanaka S, Ichikawa A, Uchiyama Y, Narushima Y, Takasawa S, Okamoto H, Tohyama M, Chiba T. Reg gene expression is increased in rat gastric enterochromaffin-like cells following water immersion stress. Gastroenterology 1996; 111: 45-55
56. Fukui H, Kinoshita Y, Maekawa T, Okada A, Waki S, Hassan S, Okamoto H, Chiba T. Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. Gastroenterology 1998; 115: 1483-1493
57. Kawanami C, Fukui H, Kinoshita Y, Nakata H, Asahara M, Matsushima Y, Kishi K, Chiba T. Regenerating gene expression in normal gastric mucosa and indomethacin-induced mucosal lesions of the rat. J Gastroenterol 1997; 32: 12-18
58. Kazurnori H, Ishihara S, Fukuda R, Kinoshita Y. Localization of Reg receptor in rat fundic mucosa. J Lab Clin Med 2002; 139: 101-108
59. Steele IA, Dimaline R, Pritchard DM, Peek RM Jr, Wang TC, Dockray GJ, Varro A. Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements. Am J Physiol Gastrointest Liver Physiol 2007; 293: G347-G354
60. Dhar DK, Udagawa J, Ishihara S, Otani H, Kinoshita Y, Takasawa S, Okamoto H, Kubota H, Fujii T, Tachibana M, Nagasue N. Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival. Cancer 2004; 100: 1130-1136
61. Sekikawa A, Fukui H, Fujii S, Takeda J, Nanakin A, Hisatsune H, Seno H, Takasawa S, Okamoto H, Fujimori T, Chiba T. REG 1alpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer. Gastroenterology 2005; 128: 642-653
62. Kawase S, Ishikura H. Female-predominant occurrence of spontaneous gastric adenocarcinoma in cotton rats. Lab Anim Sci 1995; 45: 244-248
63. Waldum HL, Rorvik H, Falkmer S, Kawase S. Neuroendocrine (ECL cell) differentiation of spontaneous gastric carcinomas of cotton rats (Sigmodon hispiclus.). Lab Anim Sci 1999; 49: 241-247
64. Martinsen TC, Kawase S, Hakanson R, Torp SH, Fossmark R, Qvigstad G, Sandvik AK, Waldum HL. Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist. Carcinogenesis 2003; 24: 1887-1896
65. Fossmark R, Martinsen TC, Torp SH, Kawase S, Sandvik AK, Waldum HL. Spontaneous enterochromaffin-like cell carcinomas in cotton rats (Sigmodon hispidus) are prevented by a somatostatin analogue. Endocr Relat Cancer 2004; 11: 149-160
66. Fossmark R, Zhao CM, Martinsen TC, Kawase S, Chen D, Waldum HL. Dedifferentiation of enterochromaffin-like cells in gastric cancer of hypergastrinemic cotton rats. APMIS 2005; 113: 436-449
67. Fossmark R, Martinsen TC, Bakkelund KE, Kawase S, Waldum HL. ECL-cell derived gastric cancer in male cotton rats dosed with the H2-blocker loxtidine. Cancer Res 2004; 64: 3687-3693
68. Fossmark R, Martinsen TC, Bakkelund KE, Kawase S, Torp SH, Waldum HL. Hypergastrinaemia induced by partial corpectomy results in development of enterochromaffin-like cell carcinoma in male Japanese cotton rats. Scand J Gastroenterol 2004; 39: 919-926
69. Modlin IM, Himi K, Bilchik AJ, Nilsson O, Esterline WJ, Goldenring JR. Pathobiology of enterochromaffin-like cell tumor induction in mastomys. In Hakanson R, Sundler F. The stomach as an endocrine organ. Amsterdam: Elsevier, 1991: 499-514
70. Schaffer K, McBride EW, Beinborn M, Kopin AS. Interspecies polymorphisms confer constitutive activity to the Mastomys cholecystokinin-B/ gastrin receptor. J Biol Chem 1998; 273: 28779-28784
71. Bilchik AJ, Nilsson O, Modlin IM, Sussman J, Zucker KA, Adrian TE. H2-receptor blockade induces peptide YY and enteroglucagon-secreting gastric carcinoids in mastomys. Surgery 1989; 106:1119-1126; discussion 1026-1027
72. Nilsson O, Wangberg B, Johansson L, Modlin IM, Ahlman H. Praomys (Mastomys) natalensis: a model for gastric carcinoid formation. Yale J Biol Med 1992; 65: 741-751; discussion 827-829
73. Chiba T, Kinoshita Y, Sawada M, Kishi K, Baba A, Hoshino E. The role of endogenous gastrin in the development of enterochromaffin-like cell carcinoid tumors in Mastomys natalensis: a study with the specific gastrin receptor antagonist AG-041R. Yale J Biol Med 1998; 71: 247-255
74. Modlin IM, Kumar R, Nangia A, Soroka CJ, Pasikhov D, Goldenring JR. Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas. Surgery 1992; 112: 1048-1056; discussion 1056-1058
75. Honda S, Fujioka T, Tokieda M, Satoh R, Nishizono A, Nasu M. Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils. Cancer Res 1998; 58: 4255-4259
76. Hirayama F, Takagi S, Iwao E, Yokoyama Y, Haga K, Hanada S. Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils. J Gastroenterol 1999; 34: 450-454
77. Kagawa J, Honda S, Kodama M, Sato R, Murakami K, Fujioka T. Enterocromaffin-like cell tumor induced by Helicobacter pylori infection in Mongolian gerbils. Helicobacter 2002; 7: 390-397
78. Nozaki K, Shimizu N, Tsukamoto T, Inada K, Cao X, Ikehara. Y, Kaminishi M, Sugiyama A, Tatematsu M. Reversibility of heterotopic proliferative glands in glandular stomach of Helicobacter pylori-infected Mongolian gerbils on eradication. Jpn J Cancer Res 2002; 93: 374-381
79. Fukui H, Franceschi F, Penland RL, Sakai T, Sepulveda AR, Fujimori T, Terano A, Chiba T, Genta RM. Effects of Helicobacter pylori infection on the link between regenerating gene expression and serum gastrin levels in Mongolian gerbils. Lab Invest 2003; 83: 1777-1786
80. Safholm C, Havu N, Forssell H, Sundell G, Mattsson H. Effect of 7 years' daily oral administration of omeprazole to beagle dogs. Digestion 1994; 55: 139-147